|
Indian pharma credits its success on patient trust in the medicines it manufactures: Jatish Sheth
|
|
Nandita Vijayasimha, Bengaluru
January 03 , 2024
|
|
|
The Indian pharmaceutical industry credits its success on patient trust in the medicines it manufactures, said Jatish N Sheth, co-chairman, Karnataka Drugs and Pharmaceutical Manufacturers Association and director, Srushti Pharma.
This is notwithstanding the Indian pharma industry being distraught after its image getting tarnished in October 2022, following the World Health Organisation’s alert against four contaminated drugs that resulted in the fatality of 66 children in Gambia and the ophthalmic drops contamination recall among others.
Such a practice is undertaken by a section of unscrupulous section in the Indian pharma industry but casts a shadow of quality adherence mistrust and unreliability, bringing every industry under the regulatory lens for no fault of theirs, said Sheth.
Noting that there are about 10,00,000 doctors in India, Sheth, said, “A medical practitioner on an average sees 25 patients in day. This accounts for an approximate 25 prescriptions per day per doctor and at a rough estimate about 2.5 crore prescriptions per day are generated and the medicines dispensed.
The patients take the medicine we manufacture with a lot of faith that they will get relief from what they are suffering from. That faith is on the medicine which we manufacture. This is also true with other 199 countries to which India exports medicines and that is why world recognises us as the global pharmacy.
In his welcome address at the Pharmexcil event in Bengaluru focusing on capacity building programme on importance of quality compliance and patient safety: Industry practices and regulatory expectations, Sheth said that during the Covid pandemic of 2020-2022, Indian pharma industry in general and Karnataka pharma companies in particular efficiently manufactured and distributed the required medicine, related medical supplies and diagnostic devices. Here the industry and the regulators were recognized, applauded and praised by everyone for the type of work and medicines made available to the patients.
But with the contaminated cough syrups seizes, our image has been taken a beating. To this end, we need to make sure that such incidences are never repeated. It is the patient who has trust in our medicines and they have never seen us. Our concerted efforts need to ensure that we continue to gain the patient confidence on the medicines we supply. This is because Indian pharma credits its success on patient trust in the medicines it manufactures, said Sheth.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|